The Australia and New Zealand fontan registry: Description and initial results from the first population-based fontan registry

Internal Medicine Journal

Volumn 44, Issue 2, 2014, Pages 148-155

  Iyengar, A J ^a,b   Winlaw, D S ^b   Galati, J C ^a,c,d   Gentles, T L ^e   Weintraub, R G ^a,b,f   Justo, R N ^g   Wheaton, G R ^h   Bullock, A ⁱ   Celermajer, D S ^j,k   d'Udekem, Y ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h MATER CHILDREN S HOSPITAL   (Australia)

ⁱ WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^j PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^k STARSHIP CHILDREN S HOSPITAL   (New Zealand)

more..

Author keywords

Congenital; Fontan procedure; Heart defect; Outcome assessment (healthcare); Registry; Research design

Indexed keywords

ADOLESCENT; ADULT; AUSTRALIA; CLASSIFICATION; CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; FONTAN PROCEDURE; HEALTH SERVICE; HEART DEFECTS, CONGENITAL; HUMAN; LONG TERM CARE; MALE; MULTICENTER STUDY; NEW ZEALAND; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; POSTOPERATIVE PERIOD; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AUSTRALIA; DATABASES, FACTUAL; FEMALE; FONTAN PROCEDURE; HEALTH SERVICES NEEDS AND DEMAND; HEART DEFECTS, CONGENITAL; HUMANS; LONG-TERM CARE; MALE; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; POSTOPERATIVE PERIOD; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84894048989     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12318     Document Type: Article

References (26)

1. Steinberger EK, Ferencz C, Loffredo CA. Infants with single ventricle: a population-based epidemiological study. Teratology 2002; 65: 106-115.
2. Schwedler G, Lindinger A, Lange PE, Sax U, Olchvary J, Peters B etal. Frequency and spectrum of congenital heart defects among live births in Germany: a study of the competence network for congenital heart defects. Clin Res Cardiol 2011; 100: 1111-1117.
3. Jacobs JP, Jacobs ML, Mavroudis C, Lacour-Gayet F. The Society of Thoracic Surgeons (STS), Duke Clinical Research Institute (DCRI). STS Congenital Heart Surgery Executive Summary. Durham, NC: Duke University Medical Centre. 2013; 1-3 [cited 2013 Apr 10]. Available from URL: http://www.sts.org/sites/default/files/documents/STSExecSummary_AllPatients_0.pdf
4. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348-1352.
5. Anne P, Du W, Mattoo TK, Zilberman MV. Nephropathy in patients after Fontan palliation. Int J Cardiol 2009; 132: 244-247.
6. Vallabhajosyula P, Komlo C, Wallen TJ, Olthoff K, Pochettino A. Combined heart-liver transplant in a situs-ambiguous patient with failed Fontan physiology. J Thorac Cardiovasc Surg 2013; 145: e39-41.
7. Iyengar AJ, Shann F, Cochrane AD, Brizard CP, d'Udekem Y. The Fontan procedure in Australia: a population-based study. J Thorac Cardiovasc Surg 2007; 134: 1353-1354.
8. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240-248.
9. Tu JV, Willison DJ, Silver FL, Fang J, Richards JA, Laupacis A etal. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 2004; 350: 1414-1421.
10. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
11. Australian Bureau of Statistics. 2006 Census Data [Internet]. Canberra: Australian Bureau of Statistics; 2007. [cited 2013 May 27]. Available from URL: http://www.censusdata.abs.gov.au/
12. New Zealand Census of Population and Dwellings. Statistics New Zealand; 2006. [cited 2013 May 27]. Available from URL: http://www.stats.govt.nz/Census/2006CensusHomePage.aspx
13. Sleeper LA, Anderson P, Hsu DT, Mahony L, McCrindle BW, Roth SJ etal. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J 2006; 152: 427-433.
14. Diller G-P, Giardini A, Dimopoulos K, Gargiulo G, Müller J, Derrick G etal. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010; 31: 3073-3083.
15. Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT etal. Hypoplastic left heart syndrome. J Am Coll Cardiol 2012; 59(Suppl): S1-S42.
16. Rogers LS, Glatz AC, Ravishankar C, Spray TL, Nicolson SC, Rychik J etal. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol 2012; 60: 1018-1025.
17. Opocher F, Varnier M, Sanders SP, Tosoni A, Zaccaria M, Stellin G etal. Effects of aerobic exercise training in children after the Fontan operation. Am J Cardiol 2005; 95: 150-152.
18. Reid GJ, Irvine MJ, McCrindle BW, Sananes R, Ritvo PG, Siu SC etal. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics 2004; 113: e197-205.
19. Yeung E, Kay J, Roosevelt GE, Brandon M, Yetman AT. Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol 2008; 125: 62-65.
20. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD etal. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 2011; 123: 1185-1193.
21. Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B etal. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 2011; 58: 645-651.
22. Schuuring MJ, Vis JC, van Dijk APJ, van Melle JP, Vliegen HW, Pieper PG etal. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail 2013; 15: 690-698.
23. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997; 96: 1507-1512.
24. Goldstein BHB, Sandelin AMA, Golbus JRJ, Warnke NN, Gooding LL, King KKK etal. Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation. Congenit Heart Dis 2012; 7: 226-234.
25. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C. Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 2002; 105: 207-212.
26. Ovaert C, Thijs D, Dewolf D, Ottenkamp J, Dessy H, Moons P etal. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young 2009; 19: 331-339.